| Original language | English (US) |
|---|---|
| Pages (from-to) | 424-428 |
| Number of pages | 5 |
| Journal | ACS Infectious Diseases |
| Volume | 4 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 13 2018 |
Bibliographical note
Funding Information:These unique features motivated the Society for Chemistry and Industry (SCI) and Royal Society of Chemistry (RSC) to organize a scientific meeting focused on drug discovery for global health (SCI/RSC Symposium on Medicinal Chemistry for Global Health).2 Like the inaugural meeting in 2014,3 the second was convened at GlaxoSmithKline (GSK) in Tres Cantos, Spain during the 18th−20th of June 2017. The three-day meeting brought together scientists from more than 15 countries working on malaria, Chagas disease, leishmaniasis, African trypanosomiasis, tuberculosis, diarrheal diseases, viral diseases (Dengue, Zika, hepatitis), schistosomiasis, filariasis and other neglected tropical diseases. The forum was also an opportunity to understand operating models and portfolios from funding agencies like the Wellcome Trust (WT), Medicines from Malaria Venture (MMV), the Bill and Melinda Gates Foundation (BMGF), and Drugs for Neglected Disease Initiative (DNDi). The meeting was divided in six sessions centered on a particular topic, disease or group of related diseases, except the last one, which was a mixture.